New board members bring a new level of respiratory and financial expertise to the company.
3 August, 2021, Dublin – patientMpower announced today the appointment of two new members to the board of directors.
New board members Kay Boycott and Frank Byrne have extensive experience in digital and healthcare spaces. Boycott has substantial Non-Executive experience including current roles as a Non-Executive Director of Imperial College Healthcare NHS Trust, Private Healthcare Information Network and Durham University. Following an international commercial career, Boycott was Chief Executive for Asthma UK for over six years, leading them through a successful merger with the British Lung Foundation. Boycott has also served as a member of the King’s Fund General Advisory Council and NHS Net Zero Expert Panel, as a Board member for the Association of Medical Research Charities and has co-authored publications on digital health. Byrne brings extensive financial experience from his many years as a Chartered Accountant, he currently works as Chartered Director and Partner at Olympia Capital, with previous specialised experience in Healthcare working as CFO for St Patricks Mental Health Services for nearly ten years, and previously as CFO for the Beacon Medical Group.
“I’m delighted to welcome Kay and Frank to the board, and look forward to working with them in helping position and grow patientMpower as a leader in virtual care delivery as health systems recover from COVID-19” said CEO, Eamonn Costello. “
Kay Boycott said, “Evidence shows that empowering people with high quality, digital health products can help improve health outcomes and deliver more sustainable healthcare. I’m looking forward to bringing my diverse experience and passion for patient centred healthcare to patientMpower.”
“I am delighted to be joining Eamonn and the team at patientMpower and look forward to contributing to the continuing success of the company”, said Frank Byrne.
patientMpower is an experienced provider of virtual care solutions for a number of respiratory, renal and cardiac conditions including COPD, idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD), lung transplant, cystic fibrosis (CF), kidney transplant and heart failure.
If you have any questions or would like to find out more about patientMpower contact us using the form below, or book in for a product demo with a member of our sales team at your convenience here (US time zones book here).
Meghan Kerr – Marketing Executive
+353 1 903 8558